Investors / Canada / Novateur Ventures
Novateur Ventures
Investor · Vancouver, Canada · North America
Novateur Ventures is a life sciences advisory and investment firm that assembles tailored teams of expert advisors to support biotechnology, pharmaceutical, medical device and digital health companies. It provides services across business and product development, due diligence, company creation and project execution.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechnologypharmaceuticalsmedical devicesdigital health
Your fit with Novateur Ventures
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsNovateur Ventures lists 43 checked portfolio companies on its own site. Its largest themes are Healthcare & Biotech (75%), AI & Machine Learning (8%) and Consumer (2%). 72% of its companies are based in Canada. It invests most often alongside Creative Destruction Lab, IndieBio and Red Thread Ventures.
No funding round on record names Novateur Ventures yet, so the figures come from its portfolio page.
Round figures show recent activity, not Novateur Ventures' whole history. Rounds on record name 0 companies; its own site lists 43. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 75% | 15% |
| AI & Machine Learning | 8% | 18% |
| Consumer | 2% | 3% |
| Industrial & Manufacturing | 2% | 7% |
| Food & Agriculture | 2% | 3% |
| Enterprise Software | 2% | 8% |
| Climate & Energy | 2% | 1% |
| Fintech | 2% | 12% |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Creative Destruction Lab | 6 |
| IndieBio | 2 |
| Red Thread Ventures | 2 |
| SOSV | 2 |
| T1D Fund | 2 |
| 11.2 Capital | 1 |
| 7G BioVentures | 1 |
| ACET Capital | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 78th | 42 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 93th | 75% in its largest sector |
| Reach | 78th | 5 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers4298%
- No longer answers00%
- Points to another company12%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Creative Destruction Lab
Compare Novateur Ventures head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
43 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| adMare partners with innovators and entrepreneurs to build a pipeline of strong, investable Canadian life sciences companies with national and global impact. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Aspect Biosystems develops bioprinted tissue therapeutics to treat diseases | Healthcare & Biotech | Portfolio page | ||
| Beyond Air develops and commercializes products that generate nitric oxide for medical use | Healthcare & Biotech | Portfolio page | ||
| BigBang Angels is an early-stage institutional investor focusing on cross-border startups. | AI & Machine LearningHealthcare & Biotech | Portfolio page | ||
| The company champions for bringing new treatments to patients with serious medical conditions and supports policies that promote innovation and improve patient access. | Healthcare & Biotech | Portfolio page | ||
| bioLytical develops and sells medical testing products, including HIV and COVID-19 tests. | Healthcare & Biotech | Portfolio page | ||
| CSN Pharma manufactures supplements for other companies | Healthcare & Biotech | Portfolio page | ||
| The company invests in biotech companies and assets | Healthcare & Biotech | Portfolio page | ||
| Daewoong develops and produces pharmaceuticals | Healthcare & Biotech | Portfolio page | ||
| Deep Genomics develops genetic medicines using artificial intelligence | Healthcare & Biotech | Portfolio page | ||
| Diadem Biotherapeutics engineers extracellular vesicles to treat cancer, autoimmune and neuroimmune conditions. | Healthcare & Biotech | Portfolio page | ||
| Edenbridge integrates medical and personal care into a system that works for elders – at our centers, in elders’ homes and as part of a community. | Healthcare & Biotech | Portfolio page | ||
Healthcare & BiotechConsumer | Portfolio page | |||
| Epitopea develops cancer RNA immunotherapies | Healthcare & Biotech | Portfolio page | ||
| Eupraxia Pharmaceuticals is a clinical-stage biotechnology company developing targeted therapies that leverage a proprietary extended-release delivery system | Healthcare & Biotech | Portfolio page | ||
| ExCellThera is an advanced clinical-stage company specializing in cell expansion and engineering, providing molecules and bioengineering solutions to expand and modify various cell lines for use in innovative single-use curative therapies for patients with hematological malignancies and other diseases. | Healthcare & Biotech | Portfolio page | ||
| Génome Québec is an enterprise that conducts genomic research | Healthcare & Biotech | Portfolio page | ||
| GenXys connects data, decisions, access, workflows, and outcomes into configurable intelligence that works where healthcare already happens. | Healthcare & Biotech | Portfolio page | ||
| Greenfield Global produces and delivers high-purity alcohols, specialty solvents, custom blends, bioprocessing inputs, and low-carbon fuels | Industrial & ManufacturingFood & Agriculture | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- novateur.ca
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 43
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Novateur Ventures' profile as data
Pull Novateur Ventures' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/novateur.ca
# also
GET /v1/firms/novateur.ca/portfolio
GET /v1/firms/novateur.ca/coinvestors
GET /v1/firms/novateur.ca/news